Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AI-061 |
Synonyms | |
Therapy Description |
Limited information is currently available on AI-061, a putative coformulation of the anti-PD-1 antibody AI-025 and the anti-CTLA antibody ONC-392 (May 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AI-061 | AI 061|AI061 | CTLA4 Antibody 29 PD-L1/PD-1 antibody 117 | Limited information is currently available on AI-061, a putative coformulation of the anti-PD-1 antibody AI-025 and the anti-CTLA antibody ONC-392 (May 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05858736 | Phase I | AI-061 | Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors (PRESERVE-009) | Recruiting | AUS | 0 |